ABBOTT LABORATORIES R&D Expense 2012-2026 | ABT
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is ABBOTT LABORATORIES's current r&d expense?
ABBOTT LABORATORIES (ABT) annual r&d expense for 2025 was $2.94B, a 3.45% increase from 2024. ABBOTT LABORATORIES r&d expense for the quarter ending March 31, 2026 was $767.0M.
What was ABBOTT LABORATORIES's r&d expense in 2024?
ABBOTT LABORATORIES annual r&d expense for 2024 was $2.84B, a 3.76% increase from 2023.
What was ABBOTT LABORATORIES's r&d expense in 2023?
ABBOTT LABORATORIES annual r&d expense for 2023 was $2.74B, a 5.09% decline from 2022.
What is ABBOTT LABORATORIES's 5-year r&d expense CAGR?
ABBOTT LABORATORIES r&d expense grew at a compound annual growth rate (CAGR) of 3.98% from FY2020 to FY2025, going from $2.42B to $2.94B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+4.0%
FY2020
$2.42B
→
FY2025
$2.94B
171819202122232425
5 years selected
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →